Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression

Gamma delta (γδ) T cells, which possess potent cytotoxicity against a wide range of cancer cells, have become a potential avenue for adoptive immunotherapy. Decitabine (DAC) has been reported to enhance the immunogenicity of tumor cells, thereby reinstating endogenous immune recognition and tumor ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chao, Li, Min, Zhu, Shan, Chen, Yongchong, Zhou, Lei, Xu, Dongsheng, Li, Wei, Cui, Jiuwei, Liu, Yongjun, Chen, Jingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879086/
https://www.ncbi.nlm.nih.gov/pubmed/29632540
http://dx.doi.org/10.3389/fimmu.2018.00617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879086/
https://www.ncbi.nlm.nih.gov/pubmed/29632540
http://dx.doi.org/10.3389/fimmu.2018.00617

Ejemplares similares